4'-[(1,4'-二甲基-2'-丙基[2,6'-联-1H-苯并咪唑]-1'-基)甲基]联苯-2-甲腈

更新时间:2024-01-04 16:50:03

4'-[(1,4'-二甲基-2'-丙基[2,6'-联-1H-苯并咪唑]-1'-基)甲基]联苯-2-甲腈结构式
4'-[(1,4'-二甲基-2'-丙基[2,6'-联-1H-苯并咪唑]-1'-基)甲基]联苯-2-甲腈结构式
品牌特惠专场
常用名 4'-[(1,4'-二甲基-2'-丙基[2,6'-联-1H-苯并咪唑]-1'-基)甲基]联苯-2-甲腈 英文名 4'-[(1,4'-Dimethyl-2'-propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carbonitrile
CAS号 144702-27-2 分子量 495.61700
密度 1.188g/cm3 沸点 775.126ºC at 760 mmHg
分子式 C33H29N5 熔点 181.2-182.1 ºC
MSDS N/A 闪点 422.581ºC

 名称

中文名 4'-[(1,4'-二甲基-2'-丙基[2,6'-联-1H-苯并咪唑]-1'-基)甲基]联苯-2-甲腈
英文名 2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzonitrile
英文别名 更多

 物理化学性质

密度 1.188g/cm3
沸点 775.126ºC at 760 mmHg
熔点 181.2-182.1 ºC
分子式 C33H29N5
分子量 495.61700
闪点 422.581ºC
精确质量 495.24200
PSA 59.43000
LogP 7.43788
蒸汽压 0mmHg at 25°C
折射率 1.664
水溶解性 Insuluble (5.0E-6 g/L) (25 ºC)

 合成线路

~89%

4'-[(1,4'-二甲基-2'-丙基[2,6'-联-1H-苯并咪唑]-1'-基)甲基]联苯-2-甲腈结构式

4'-[(1,4'-二甲基-2...

144702-27-2

文献:Boehringer Ingelheim International GmbH Patent: US2004/236113 A1, 2004 ; Location in patent: Page 4 ;

~%

4'-[(1,4'-二甲基-2'-丙基[2,6'-联-1H-苯并咪唑]-1'-基)甲基]联苯-2-甲腈结构式

4'-[(1,4'-二甲基-2...

144702-27-2

文献:U AMARNATH, Amarnath; U SURYAKIRAN, Suryakiran Patent: WO2014/27280 A1, 2014 ; Location in patent: Page/Page column 6-7 ;

~87%

4'-[(1,4'-二甲基-2'-丙基[2,6'-联-1H-苯并咪唑]-1'-基)甲基]联苯-2-甲腈结构式

4'-[(1,4'-二甲基-2...

144702-27-2

文献:KRKA, TOVARNA ZDRAVIL, D.D., NOVO MESTO Patent: WO2009/4064 A1, 2009 ; Location in patent: Page/Page column 39-40 ;

~87%

4'-[(1,4'-二甲基-2'-丙基[2,6'-联-1H-苯并咪唑]-1'-基)甲基]联苯-2-甲腈结构式

4'-[(1,4'-二甲基-2...

144702-27-2

文献:KRKA, TOVARNA ZDRAVIL, D.D., NOVO MESTO Patent: WO2009/4064 A1, 2009 ; Location in patent: Page/Page column 42 ;

~%

4'-[(1,4'-二甲基-2'-丙基[2,6'-联-1H-苯并咪唑]-1'-基)甲基]联苯-2-甲腈结构式

4'-[(1,4'-二甲基-2...

144702-27-2

文献:WO2010/146187 A2, ; Page/Page column 40-41 ;

~45%

4'-[(1,4'-二甲基-2'-丙基[2,6'-联-1H-苯并咪唑]-1'-基)甲基]联苯-2-甲腈结构式

4'-[(1,4'-二甲基-2...

144702-27-2

文献:KRKA, TOVARNA ZDRAVIL, D.D., NOVO MESTO Patent: WO2009/4064 A1, 2009 ; Location in patent: Page/Page column 44 ;

~%

4'-[(1,4'-二甲基-2'-丙基[2,6'-联-1H-苯并咪唑]-1'-基)甲基]联苯-2-甲腈结构式

4'-[(1,4'-二甲基-2...

144702-27-2

文献:WO2014/27280 A1, ;

 英文别名

BIP007
2-Descarboxy-2-cyano Telmisartan
Telmisartan Impurity G
UNII-A8M0GXG1XV
(1,1'-Biphenyl)-2-carbonitrile,4'-((1,4'-dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)
4'-[[2-n-propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)-benzimidazol-1-yl]-methyl]-2-cyano-biphenyl
4'-[[2-n-propyl-4-methyl-6-(1-methyl-benzimidazol-2-yl)-1H-benzimidazol-1-yl]-methyl]-2-cyano-biphenyl
4'-{[2-n-propyl-4-methyl-6-(1-methylbenzoimidazol-2-yl)benzoimidazol-1-yl]methyl}-2-cyanobiphenyl
Telmisartan impurity G [EP]
2-cyano-4'-[2''-n-propyl-4''-methyl-6''-(1'''-methylbenzimidazole-2'''-yl)benzimidazole-1''-ylmethyl]biphenyl
2-cyano-4'-(2''-n-propyl-4''-methyl-6''-(1'''-methylbenzimidazol-2'''-yl)benzimidazol-1''-ylmethyl)biphenyl
4'-[(1,4'-Dimethyl-2'-propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carbonitrile
Telmisartan Impurity 7